Q32 Bio delivers 23.91% average annual return over five years
Q32 Bio reported an average annual return of 23.91% over the last five years, surpassing the market by 11.82% annually. With a current market cap of $317.42 million, a $100 stake from five years ago is now worth $287.54.
*this image is generated using AI for illustrative purposes only.
Q32 Bio has generated an average annual return of 23.91% over the past five years, outperforming the market by 11.82% on an annualized basis. The company currently holds a market capitalization of $317.42 million.
Investment Growth Analysis
The performance of Q32 Bio highlights the impact of compounded returns on capital growth over time. Based on the current stock price of $18.72, an initial investment made five years ago has seen significant appreciation.
| Investment Period | Initial Investment | Current Value | Current Price |
|---|---|---|---|
| 5 Years | $100 | $287.54 | $18.72 |
The data illustrates how long-term holding periods can magnify returns through annualized growth.
What factors could sustain Q32 Bio's outperformance relative to the market in the next five years?
How might changes in market capitalization impact the company's growth trajectory?
What are the potential risks that could derail Q32 Bio's current annualized return rate?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
